"..to take it to the market takes terrific people"
The new CEO of Fluxome, Angela Tsetsis, wants to use her many years of experience specifically to improve the commercial aspects of the company.
af KRESTEN MORTEN MUNKSGAARD
The Danish biotech company Fluxome has just hired Angela Tsetsis as its new CEO. The American has been with the biotech company Martek for the last 19 years, and played a huge part in the commercialization process that lead to the company being bought by the Dutch food supplement company DSM.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
